QIM
SGMO

Quantitative Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Quantitative Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-90,260
Closed -$1.41M – 645
2020
Q4 		$1.41M Buy
+90,260
New +$1.06M 0.11% 200
2020
Q3 		– Sell
-86,145
Closed -$771K – 577
2020
Q2 		$771K Buy
+86,145
New +$799K 0.08% 260
2019
Q2 		– Sell
-84,000
Closed -$801K – 806
2019
Q1 		$801K Buy
84,000
+67,800
+419% +$692K 0.05% 406
2018
Q4 		$185K Sell
16,200
-21,000
-56% -$261K 0.01% 501
2018
Q3 		$630K Buy
+37,200
New +$565K 0.02% 381
2015
Q4 		– Sell
-45,100
Closed -$254K – 825
2015
Q3 		$254K Buy
+45,100
New +$372K 0.02% 566
2014
Q3 		– Sell
-12,900
Closed -$196K – 484
2014
Q2 		$196K Sell
12,900
-44,400
-77% -$639K 0.04% 404
2014
Q1 		$1.03M Buy
+57,300
New +$1.1M 0.05% 240

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Quantitative Investment Management's SGMO Position: Q1 2021 in Review

Quantitative Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 90,260 shares — an estimated $1.41M sold.

Quantitative Investment Management first reported a position in SGMO in Q1 2014 and held it in 8 quarters. The position peaked at $1.41M in Q4 2020. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

  • Quantitative Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 90,260 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $1.41M.
  • Quantitative Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 8 quarters.
  • Quantitative Investment Management's SANGAMO THERAPEUTICS INC position peaked at $1.41M in Q4 2020.
  • 203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on Quantitative Investment Management's 13F filing for Q1 2021, filed 17 May 2021.